同期外科房颤消融改善长期生存:多中心分析
该多中心回顾性分析纳入2008至2015年七中心20407例连续CABG或瓣膜手术中2740例术前有房颤记录的患者,比较同期行外科消融(SA)与未行SA者的全因死亡。SA频率23.1%,风险校正后SA组5年生存更优(HR 0.69,95%CI 0.51–0.92),支持STS指南更广泛应用同期SA。
要点
- 术前房颤患者行CABG或瓣膜手术时,同期SA与更好的长期生存相关
- 风险校正后SA组5年生存HR 0.69(95%CI 0.51–0.92),各术式均可见获益
- SA未增加术后并发症,但体外循环时间更长、总住院时间更短
核心结论
- 在术前房颤的多中心队列中,同期SA使CABG、瓣膜及瓣膜加CABG患者长期生存显著改善,支持STS指南更广泛应用的推荐。
研究设计与样本
- 七中心前瞻性维护临床注册数据的回顾性分析,纳入2008至2015年20407例连续CABG或瓣膜手术中2740例术前有房颤记录者。
主要发现
- SA频率23.1%(n=634),研究期间SA率上升(p < 0.001)。
- CABG中同期SA占16.2%,瓣膜手术占30.6%,瓣膜加CABG占24.3%。
- 未校正生存SA组显著改善(HR 0.54,95%CI 0.42–0.70),术后并发症无差异。
- SA组体外循环时间更长(p < 0.001)但总住院时间更短(p < 0.001)。
- 风险校正后SA组5年生存改善(HR 0.69,95%CI 0.51–0.92),各术式均可见。
关键数值与推荐
- STS指南推荐在同期二尖瓣手术、主动脉瓣置换、CABG及主动脉瓣置换加CABG时对房颤患者行SA。
- 风险校正后SA组5年生存HR 0.69(95%CI 0.51–0.92)。
临床怎么用
- 对拟行CABG或瓣膜手术的术前房颤患者,可考虑同期SA以改善长期生存,并注意体外循环时间延长。
局限性
- 原文为回顾性分析,未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Society of Thoracic Surgeons guidelines recommend surgical ablation (SA) at the time of concomitant mitral operations, aortic valve replacement, coronary artery bypass grafting (CABG), and aortic valve replacement plus CABG for patients in atrial fibrillation (AF). The goal of this analysis was to assess the influence of SA on long-term survival. METHODS: A retrospective analysis of 20,407 consecutive CABG or valve procedures from 2008 to 2015 among seven centers reporting to a prospectively maintained clinical registry was conducted. Patients undergoing operation with documented preoperative AF were included (n = 2,740). Patients receiving SA were compared with patients receiving no SA. The primary end point was all-cause mortality. Secondary end points included in-hospital morbidity and mortality. RESULTS: The frequency of SA was 23.1% (n = 634), and an increase was seen in the rate of SA over the study period (p < 0.001). Concomitant SA was performed in 16.2% of CABG, 30.6% of valve, and 24.3% of valve plus CABG procedures. A substantial improvement was found in unadjusted survival among patients undergoing SA (hazard ratio 0.54, 95% confidence interval: 0.42 to 0.70). Moreover, no differences were found in postoperative complications. SA did have longer bypass times (p < 0.001) but a shorter overall length of stay (p < 0.001). After risk adjustment, SA patients had an improved 5-year survival (hazard ratio 0.69, 95% confidence interval: 0.51 to 0.92), and the effect was observed across all operations. CONCLUSIONS: In a multicenter cohort of patients with AF, concomitant SA resulted in substantially improved long-term survival across patients who underwent CABG, valve, and valve plus CABG. These findings support current guidelines from The Society of Thoracic Surgeons that recommend broader application of concomitant SA.
引用
- Iribarne A, DiScipio AW, McCullough JN, et al. Surgical Atrial Fibrillation Ablation Improves Long-Term Survival: A Multicenter Analysis. Ann Thorac Surg. 2018. PMID: 30300644. doi:10.1016/j.athoracsur.2018.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。